$29.84 0.00 (%) Pfizer Inc - NYSE

Oct. 30, 2014 | 04:00 PM

Partner Headlines

  1. Johnson & Johnson Fairly Valued - I Will Bet on It

    GuruFocus | Oct. 30, 2014 | 12:26PM EST
  2. Buybacks-Driven Market: Engineered Too Far?

    YCharts | Oct. 29, 2014 | 12:36PM EST
  3. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases

    Benzinga | Oct. 29, 2014 | 07:50AM EST
  4. Pfizer Q3 beats views

    IBD | Oct. 28, 2014 | 18:46PM EST
  5. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  6. Fast Money Traders Take Position On Stocks Making Headlines

    Benzinga | Oct. 28, 2014 | 15:59PM EST
  7. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  8. Pfizer Conference Call Highlights

    Benzinga | Oct. 28, 2014 | 15:36PM EST
  9. Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline

    Benzinga | Oct. 28, 2014 | 13:50PM EST
  10. Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View

    Benzinga | Oct. 28, 2014 | 11:06AM EST
  11. UPDATE: Pfizer Posts Stronger-Than-Expected Q3 Earnings

    Benzinga | Oct. 28, 2014 | 08:09AM EST
  12. 10 Stocks You Should Be Watching Today

    Benzinga | Oct. 28, 2014 | 04:16AM EST
  13. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  14. My 5 Favorite Stocks With Dividend Growth Of The Week

    GuruFocus | Oct. 27, 2014 | 12:09PM EST
  15. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 27, 2014 | 10:33AM EST
  16. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  17. Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More

    Benzinga | Oct. 26, 2014 | 16:55PM EST
  18. Markets End Hectic Week On Positive Note

    Benzinga | Oct. 24, 2014 | 17:16PM EST
  19. Pfizer Announces Share Buyback, Shares Pop Up

    Benzinga | Oct. 24, 2014 | 13:44PM EST
  20. Stocks Cling To Decent Gains; Alibaba Nears High

    IBD | Oct. 24, 2014 | 13:25PM EST
  21. PFIZER's

    IBD | Oct. 23, 2014 | 18:56PM EST
  22. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  23. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  24. Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU

    GuruFocus | Oct. 20, 2014 | 12:03PM EST
  25. UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda

    Benzinga | Oct. 17, 2014 | 16:27PM EST
  26. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  27. Shire Can Thrive Without AbbVie, Say Analysts

    IBD | Oct. 16, 2014 | 11:19AM EST
  28. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  29. Fast Money Halftime Report Final Trade From October 13

    Benzinga | Oct. 13, 2014 | 16:17PM EST
  30. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
  31. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  32. Blackstone To Break-Up As Spin-Offs Ramp Up

    IBD | Oct. 10, 2014 | 11:02AM EST
  33. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  34. Actavis expands antibiotics

    IBD | Oct. 6, 2014 | 18:45PM EST
  35. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  36. 10 Stocks With The Highest Share Buyback Volume In 2014

    GuruFocus | Oct. 3, 2014 | 13:52PM EST
  37. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  38. Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?

    Benzinga | Sep. 29, 2014 | 12:55PM EST
  39. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  40. Focusing Solely On Animal Health Sets Zoetis Apart

    IBD | Sep. 26, 2014 | 14:37PM EST
  41. GlycoMimetics Reports Delay in Initiation of Phase 3 Trial with Rivipansel

    Benzinga | Sep. 26, 2014 | 09:03AM EST
  42. Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

    Benzinga | Sep. 25, 2014 | 20:26PM EST
  43. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  44. Pfizer

    IBD | Sep. 23, 2014 | 18:45PM EST
  45. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  46. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
  47. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
  48. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  49. Pfizer Inc. Is Kicking The Tires At Actavis PLC

    Benzinga | Sep. 23, 2014 | 14:45PM EST
  50. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 16:58PM EST
Trading Center